For instance, Du et al. found that plasma phosphorylated tau (p-tau217) exhibited higher discriminative accuracy for AD than amyloid PET, indicating that tau pathology may serve as a more reliable predictor of cognitive decline [21]. The gene discussed is MAPT; the disease is Alzheimer disease.